Editas Medicine (EDIT) Assets Average (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Assets Average data on file, last reported at $194.1 million in Q4 2025.

• Assets Average for Q4 2025 came in at $194.1 million, down 41.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $194.1 million (down 41.97% YoY), and the FY2025 annual result was $264.1 million, down 37.18% from the prior year.
• Assets Average slipped to $194.1 million in Q4 2025 per EDIT's latest filing, from $206.2 million in the prior quarter.
• Over five years, Assets Average peaked at $768.1 million in Q2 2021 and troughed at $194.1 million in Q4 2025.
• A 5-year average of $487.0 million and a median of $502.5 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2025: Assets Average jumped 38.67% in 2021, then plunged 42.53% in 2025.
• A 5-year view of Assets Average shows it stood at $697.3 million in 2021, then declined by 25.04% to $522.7 million in 2022, then dropped by 3.97% to $501.9 million in 2023, then sank by 33.34% to $334.6 million in 2024, then slumped by 41.97% to $194.1 million in 2025.
• Business Quant data shows EDIT's Assets Average at $194.1 million in Q4 2025, $206.2 million in Q3 2025, and $237.1 million in Q2 2025.